CN103555835A - 用于sma基因筛查的引物、探针及其使用方法 - Google Patents
用于sma基因筛查的引物、探针及其使用方法 Download PDFInfo
- Publication number
- CN103555835A CN103555835A CN201310509147.9A CN201310509147A CN103555835A CN 103555835 A CN103555835 A CN 103555835A CN 201310509147 A CN201310509147 A CN 201310509147A CN 103555835 A CN103555835 A CN 103555835A
- Authority
- CN
- China
- Prior art keywords
- seq
- primer
- probe
- combination
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 402
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 38
- 238000012216 screening Methods 0.000 title claims abstract description 20
- 208000002320 spinal muscular atrophy Diseases 0.000 title abstract description 49
- 230000004083 survival effect Effects 0.000 claims abstract description 47
- 210000003754 fetus Anatomy 0.000 claims abstract description 15
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 claims description 145
- 102100021947 Survival motor neuron protein Human genes 0.000 claims description 143
- 108010085238 Actins Proteins 0.000 claims description 103
- 102000007469 Actins Human genes 0.000 claims description 70
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 48
- 230000001537 neural effect Effects 0.000 claims description 44
- 238000012360 testing method Methods 0.000 claims description 43
- 108020004414 DNA Proteins 0.000 claims description 15
- 238000000137 annealing Methods 0.000 claims description 15
- 230000004087 circulation Effects 0.000 claims description 15
- 101150081851 SMN1 gene Proteins 0.000 claims description 13
- 230000003321 amplification Effects 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 238000012408 PCR amplification Methods 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 10
- 210000004381 amniotic fluid Anatomy 0.000 claims description 9
- 238000007400 DNA extraction Methods 0.000 claims description 8
- 101150015954 SMN2 gene Proteins 0.000 claims description 7
- 238000004925 denaturation Methods 0.000 claims description 6
- 230000036425 denaturation Effects 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 208000032225 Proximal spinal muscular atrophy type 1 Diseases 0.000 claims description 4
- 208000033522 Proximal spinal muscular atrophy type 2 Diseases 0.000 claims description 4
- 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 claims description 4
- 201000006913 intermediate spinal muscular atrophy Diseases 0.000 claims description 4
- 208000032471 type 1 spinal muscular atrophy Diseases 0.000 claims description 4
- 208000032521 type II spinal muscular atrophy Diseases 0.000 claims description 4
- 208000032527 type III spinal muscular atrophy Diseases 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 210000002161 motor neuron Anatomy 0.000 abstract description 4
- 230000001605 fetal effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 101150113275 Smn gene Proteins 0.000 description 3
- 208000025341 autosomal recessive disease Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 208000007379 Muscle Hypotonia Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000002415 kinetochore Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
引物名称 | 序列 | 序列编号 |
SMN1-F1 | 5’-CTTCCTTTATTTTCCTTACAGGGTTTC-3’ | SEQ ID No:1 |
SMN1-F2 | 5’-CCTTTATTTTCCTTACAGGGTTTCA-3’ | SEQ ID No:2 |
SMN2-F1 | 5’-CTTCCTTTATTTTCCTTACAGGGTTTT-3’ | SEQ ID No:3 |
SMN2-F2 | 5’-CCTTTATTTTCCTTACAGGGTTTTA-3’ | SEQ ID No:4 |
SMN2-F3 | 5’-TTCCTTTATTTTCCTTACAGGGTTTT-3’ | SEQ ID No:5 |
SMN2-F4 | 5’-TTCCTTTATTTTCCTTACAGGGTTTTA-3’ | SEQ ID No:6 |
SMN-R1 | 5’-AGTAAGATTCACTTTCATAATGCTGG-3’ | SEQ ID No:7 |
SMN-R2 | 5’-AACCTTTCAACTTTCTAACATCTGAACT-3’ | SEQ ID No:8 |
SMN-P1 | FAM-5’-TCAAAAAGAAGGAAGGTGCTCACAT-3’-TAMRA | SEQ ID No:9 |
SMN-P2 | FAM-5’-TAAATTAAGGAGTAAGTCTGCCAGCAT-3’-TAMRA | SEQ ID No:10 |
Actin-F1 | 5’-AGGGCTTCTTGTCCTTTCC-3’ | SEQ ID No:11 |
Actin-R1 | 5’-CACCTGGGTCATCTTCTCG-3’ | SEQ ID No:12 |
Actin-P1 | HEX-5’-CAACTGGGACGACATGGAGAAAATC-3’-TAMRA | SEQ ID No:13 |
Actin-F2 | 5’-CTCGCTGTCCACCTTCCA-3’ | SEQ ID No:14 |
Actin-R2 | 5’-CGACTGCTGTCACCTTCAC-3’ | SEQ ID No:15 |
Actin-P2 | HEX-5’-CTATGACTTAGTTGCGTTACACCCTTTC-3’-TAMRA | SEQ ID No:16 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310509147.9A CN103555835B (zh) | 2013-10-25 | 2013-10-25 | 用于sma基因筛查的引物、探针及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310509147.9A CN103555835B (zh) | 2013-10-25 | 2013-10-25 | 用于sma基因筛查的引物、探针及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103555835A true CN103555835A (zh) | 2014-02-05 |
CN103555835B CN103555835B (zh) | 2015-04-15 |
Family
ID=50010178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310509147.9A Expired - Fee Related CN103555835B (zh) | 2013-10-25 | 2013-10-25 | 用于sma基因筛查的引物、探针及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103555835B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103789440A (zh) * | 2014-02-19 | 2014-05-14 | 上海五色石医学研究有限公司 | 脊髓性肌萎缩症相关基因突变检测方法、相关检测探针组合物及检测试剂盒、以及相关应用 |
CN106520942A (zh) * | 2016-10-28 | 2017-03-22 | 苏州天隆生物科技有限公司 | 人运动神经元存活基因smn1和smn2检测试剂盒及检测方法 |
CN108456726A (zh) * | 2018-04-19 | 2018-08-28 | 深圳会众生物技术有限公司 | 脊髓性肌萎缩症基因检测探针、引物和试剂盒 |
CN110527718A (zh) * | 2018-05-25 | 2019-12-03 | 丰技生物科技股份有限公司 | Sma基因的snp位点的检测方法 |
CN111172273A (zh) * | 2020-01-19 | 2020-05-19 | 陕西师范大学 | 一种smn1基因检测的引物组、试剂盒及检测方法 |
WO2021020261A1 (ja) * | 2019-07-26 | 2021-02-04 | 積水メディカル株式会社 | Smn1遺伝子の検出又は定量方法 |
CN114317727A (zh) * | 2022-03-03 | 2022-04-12 | 上海恩元生物科技有限公司 | 用于smn基因拷贝数分析的荧光定量检测试剂及应用 |
CN116179679A (zh) * | 2022-11-07 | 2023-05-30 | 嘉检(广州)生物工程技术有限公司 | Smn1基因的检测引物对、检测探针以及用于检测脊髓性肌萎缩症的试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1769486A (zh) * | 2004-11-01 | 2006-05-10 | 苏怡宁 | 脊髓型肌肉萎缩症的鉴别方法 |
-
2013
- 2013-10-25 CN CN201310509147.9A patent/CN103555835B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1769486A (zh) * | 2004-11-01 | 2006-05-10 | 苏怡宁 | 脊髓型肌肉萎缩症的鉴别方法 |
Non-Patent Citations (2)
Title |
---|
BRUNO MARANDA ET AL: "Spinal muscular atrophy: Clinical validation of a single-tube multiplex real time PCR assay for determination of SMN1 and SMN2 copy numbers", 《CLINICAL BIOCHEMISTRY》 * |
YU HUANG LIANG ET AL: "deletion analysis of SMN1 and NAIP genes in southern Chinese children with spinal muscular atrophy", 《浙江大学学报科学技术版(英文版)》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103789440A (zh) * | 2014-02-19 | 2014-05-14 | 上海五色石医学研究有限公司 | 脊髓性肌萎缩症相关基因突变检测方法、相关检测探针组合物及检测试剂盒、以及相关应用 |
CN106520942A (zh) * | 2016-10-28 | 2017-03-22 | 苏州天隆生物科技有限公司 | 人运动神经元存活基因smn1和smn2检测试剂盒及检测方法 |
CN108456726A (zh) * | 2018-04-19 | 2018-08-28 | 深圳会众生物技术有限公司 | 脊髓性肌萎缩症基因检测探针、引物和试剂盒 |
CN110527718A (zh) * | 2018-05-25 | 2019-12-03 | 丰技生物科技股份有限公司 | Sma基因的snp位点的检测方法 |
WO2021020261A1 (ja) * | 2019-07-26 | 2021-02-04 | 積水メディカル株式会社 | Smn1遺伝子の検出又は定量方法 |
EP4006155A4 (en) * | 2019-07-26 | 2023-08-16 | Sekisui Medical Co., Ltd. | METHODS FOR DETECTING OR QUANTIFICATION OF SMN1 GENE |
CN111172273A (zh) * | 2020-01-19 | 2020-05-19 | 陕西师范大学 | 一种smn1基因检测的引物组、试剂盒及检测方法 |
CN111172273B (zh) * | 2020-01-19 | 2023-05-30 | 陕西师范大学 | 一种smn1基因检测的引物组、试剂盒及检测方法 |
CN114317727A (zh) * | 2022-03-03 | 2022-04-12 | 上海恩元生物科技有限公司 | 用于smn基因拷贝数分析的荧光定量检测试剂及应用 |
CN116179679A (zh) * | 2022-11-07 | 2023-05-30 | 嘉检(广州)生物工程技术有限公司 | Smn1基因的检测引物对、检测探针以及用于检测脊髓性肌萎缩症的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN103555835B (zh) | 2015-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103555835B (zh) | 用于sma基因筛查的引物、探针及其使用方法 | |
CN108048548A (zh) | 人脊髓性肌萎缩症致病基因拷贝数检测荧光定量pcr试剂盒 | |
CN105695567B (zh) | 一种用于检测胎儿染色体非整倍体的试剂盒、引物和探针序列及检测方法 | |
CN104630368B (zh) | 一种人运动神经元基因拷贝数相对定量检测方法及试剂盒 | |
CN103614477B (zh) | 一种诊断人类脊髓性肌萎缩症的荧光定量pcr试剂盒 | |
CN101323877B (zh) | 检测21号染色体和性染色体数目异常的试剂盒 | |
CN106755399B (zh) | 一种i型神经纤维瘤病致病突变基因及基于此突变基因的病因学诊断试剂 | |
CN103451302A (zh) | 聋病易感基因线粒体12SrDNA 1555A>G、1494C>T突变比例检测试剂盒 | |
CN105950766B (zh) | 一种用于检测hla-b*5801等位基因的引物组及试剂盒 | |
CN104087672A (zh) | 一种多重实时荧光定量pcr技术快速检测人21号染色体数目的试剂盒 | |
CN106834501A (zh) | 与中国儿童肥胖相关的单核苷酸多态性位点及其应用 | |
CN108300788A (zh) | 一种用于检测轻型脑外伤的微小核糖核酸组合及其应用 | |
CN111944893B (zh) | 与唇腭裂产前无创诊断相关的miRNA分子标志物及其应用 | |
CN111944894B (zh) | 用于唇腭裂、神经管畸形和先天性心脏病胎儿产前无创诊断的分子标志物及其应用 | |
CN110592204A (zh) | 血清miRNA组合作为分子标记物评估非阻塞性无精症 | |
CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
CN103820555A (zh) | 一种利用连锁不平衡在家系中筛查Wilson disease基因突变的方法 | |
CN108998528B (zh) | 肺癌诊断分子标记物lncRNA LINC00516和试剂盒及其应用 | |
CN113215243A (zh) | 一种用于检测slc22a5基因高频致病变异的荧光定量pcr探针引物组和试剂盒 | |
CN103074416B (zh) | 一种检测五条染色体数目异常的方法 | |
CN108018351A (zh) | 一种与摄入高脂食物所致代谢疾病相关的生物标志物及其应用 | |
CN111041086B (zh) | Rpl13基因先天性心脏病易感snp位点及其应用 | |
CN114606311B (zh) | SLC39A13基因rs755555位点的应用及其检测引物和探针组合、试剂盒 | |
CN114032297B (zh) | 一种与ICP辅助诊断相关的血清/血浆外泌体miRNA标志物及其应用 | |
CN113718025B (zh) | 一种基于kasp的用于糖尿病视网膜病变基因检测的snp试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CENG JIMENG Free format text: FORMER OWNER: RUIBAO BIO-MEDICINE TECHNOLOGY (XIAMEN) CO., LTD. Effective date: 20150303 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zeng Jimeng Inventor after: Zhuang Jianli Inventor after: Liu Bin Inventor after: Lai Jinjiao Inventor after: Guan Zhenqun Inventor before: Zeng Jimeng Inventor before: Zhuang Jianli Inventor before: Liu Bin Inventor before: Lai Jinjiao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 361115 XIAMEN, FUJIAN PROVINCE TO: 361102 XIAMEN, FUJIAN PROVINCE Free format text: CORRECT: INVENTOR; FROM: CENG JIMENG ZHUANG JIANLI LIU BIN LAI JINJIAO TO: CENG JIMENG ZHUANG JIANLI LIU BIN LAI JINJIAO GUAN ZHENQUN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150303 Address after: 361102 School of pharmacy, Xiangan campus, Xiamen University, Fujian 259, Xiamen, China Applicant after: Zeng Jimeng Address before: 301 block D, Jianye Building, industrial zone, torch hi tech Zone (Xiangan), Fujian, Xiamen 361115, China Applicant before: Rui Bao biological medicine technology (Xiamen) Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 Termination date: 20151025 |
|
EXPY | Termination of patent right or utility model |